Stock Chart

LFVN

$6.00 +0.17%
Score: 51.7 HOLD
LEAPs: SELL $8
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $8
Premium: $1.20
Expiry: Jun 18, 2026
Target: $8
Score: -82

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.66x (vs SPY: 1.3x | vs QQQ: 1.0x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 09, 2026
Symmetrical Triangle Bullish scenario quality 81/100
Measured-move target $6.32 (+5.3%) · apex ~10 bars ahead
Historically breaks up 54% overall; 71% up when formed in a downtrend (n=131)
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About LFVN - Lifevantage Corporation Common Stock (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Key Statistics

Market Cap $75M
P/E Ratio 14.98
Dividend Yield 0.03%

This LFVN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track LFVN's price movements with trendlines, gamma walls, and key support/resistance levels.